Fabtech Technologies Cleanroom IPO was open for investment from January 3 to 7. The issue received a tremendous response in three days.
On the last day of bidding, this IPO got more than 740 times subscriptions. The price band for the offer was Rs 80-85 per share.
According to a report, the GMP of Fabtech Technologies Cleanroom IPO is Rs 110. This indicates a listing with a 130% premium.
The potential listing price of the company’s share is Rs 195.
What Is The Detail?
The pre-engineered and pre-fabricated modular panels and doors manufacturer serving the pharmaceutical, healthcare, and biotech sectors aims to raise Rs 27.74 crore through the IPO offering.
Which includes only a fresh issue of 32.64 lakh shares.
Subscription data on the BSE showed that investors bid for 136.7 crore equity shares against the offer size of 23.36 lakh shares through 4.59 lakh applications.
Company Business
The Mumbai-based company provides design-to-validation solutions of pre-engineered and pre-fabricated modular panels and doors to create cleanrooms for the pharmaceutical, healthcare, and biotech sectors.
Cleanroom solutions, which are customised as per customer requirements.
Which includes wall panels, view panels, doors, risers, ceiling panels, covings, heat ventilation air conditioning (HVAC) systems, epoxy flooring, and electrification work.
Quick Fact
Company name: Fabtech Technologies Cleanroom
| Company name | Fabtech Technologies Cleanroom |
|---|---|
| IPO Open Date | January 3-7 |
| Subscription | 740 times |
| Price Band | ₹80-85 per share |
| Possible Listing Price | ₹195 |
| Possible Premium | 130% |
| IPO Size | ₹27.74 crore |
| Shares Offered | 32.64 lakh (Fresh Issue) |
| Total Bids Received | 136.7 crore shares |
| Applications Received | 4.59 lakh |
| Business Type | Cleanroom solutions |
| Target Industries | Pharmaceutical, healthcare, biotech |
| Key Products | Modular panels, doors, HVAC systems, epoxy flooring, electrics |
| Services | Design-to-validation cleanroom solutions |
| Location | Mumbai |
Disclaimer: The website and its content are for informational purposes only and should not be considered investment advice.
